Tutte le Categorie

Spectrum Business Receives Frost & Sullivan's 2025 North American Competitive…

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy innovation and customer impact. Spectrum Business, the suite of advanced connectivity and managed services for commercial customers, excels in both aligning strategic initiatives with market demand and executing them with efficiency, consistency and scale. "The Spectrum Business strategy prioritizes simplicity in its product line with a single partner providing 24/7/365…
PR Newswire
10/11/2025

In collaboration with strategic partners, Abu Dhabi Investment Office announces…

The network will comprise more than 10 state-of-the-art vertiports integrated into Abu Dhabi's wider transport system. Zayed International Airport and Al Bateen Executive Airport have been confirmed as key locations within the broader network, with further sites and intercity routes to be announced in subsequent phases. Abu Dhabi Airports has been selected as the anchor investor and will act as the primary delivery partner. Meanwhile, the Integrated Transport Centre (Abu Dhabi Mobility) and GCAA…
PR Newswire
10/11/2025

Seekr and Fossefall forge strategic partnership to bring the complete enterprise…

Across continental Europe, industrial electricity prices often exceed USD 0.15 per kWh, while in Northern Norway's NO4 region, powered almost entirely by renewable hydropower, average spot prices in 2025 were around 10 øre per kWh (~USD 0.009) (statistics Norway, Nordpool). The cool climate, abundant renewable generation, and stable political and security environment make Norway uniquely suited for high-density AI operations. A recent Fortune Business Insights report projects Europe's AI…
PR Newswire
10/11/2025

Form 8.3 - [JTC PLC - 07 11 2025] - (CGAML)

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient...
Nasdaq GlobeNewswire
10/11/2025

Novartis opens new radioligand therapy manufacturing facility in California as…

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and HawaiiFirst to have delivered at scale, Novartis fortifies leadership in RLT innovation and infrastructure with California facility, additional plans for Florida and TexasBasel, November 10, 2025– Novartis, a leading...
Nasdaq GlobeNewswire
10/11/2025

Gas Liquids Engineering Completes Issued For Construction Scope for the Ridley…

"This project represents a major milestone in Gas Liquids Engineering's portfolio of energy export and terminal facilities," said Ryan Arnold, Vice President of Projects, Gas Liquids Engineering. "We are proud to have supported AltaGas on this important initiative, and to have collaborated with industry-leading fabricators and service providers." "This project represents a major milestone in Gas Liquids Engineering's portfolio of energy export and terminal…
PR Newswire
10/11/2025

Form 8.3 - [IQE PLC - 07 11 2025] - (CGAML)

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient...
Nasdaq GlobeNewswire
10/11/2025

SUBMISSION OF REQUEST FOR THE REVISION OF THE VOLUNTARY SHARE EXCHANGE TENDER…

REISSUED - CORRECTED VERSIONANNOUNCEMENTSUBMISSION OF REQUEST FOR THE REVISION OF THE VOLUNTARY SHARE EXCHANGE TENDER OFFER MADE BY EURONEXT N.V. (“OFFEROR” OR “EURONEXT”) FOR THE ORDINARY REGISTERED SHARES OF HELLENIC EXCHANGES-ATHENS STOCK EXCHANGE S.A. (“ATHEX”)TENDER OFFER REVISION 1. In accordance with Article 21, paragraph 2 of Law 3461/2006 as in force (the “ Law ”), Euronext announces the following:a) On 30 July 2025, (the “ Date of the Tender Offer ”) the Offeror...
Nasdaq GlobeNewswire
10/11/2025

Autumn Budget: Avoid hiking employment costs, warns Employment Hero, as half of…

New research reveals that 86% of businesses are concerned about what the upcoming Budget will mean for them. This is unsurprising, given that the majority (59%) of business owners don't feel the Government takes the needs of small companies into account when making Budget decisions. New research reveals that 86% of businesses are concerned about what the upcoming Budget will mean for them. This is unsurprising, given that the majority (59%) of business owners don't feel the Government takes…
PR Newswire
10/11/2025

Form 8.3 - IDOX plc - Octopus Investments

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser:OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor...
Nasdaq GlobeNewswire
10/11/2025

Russell Reynolds Associates Names Dr. Tomas Chamorro-Premuzic as Firm's First…

As advanced technology platforms and artificial intelligence continue to transform leadership advisory services, this appointment reinforces RRA's commitment to leveraging advanced analytics to deepen client impact worldwide. Dr. Chamorro-Premuzic's role represents a critical new capability, focusing on the content and process aspects of the firm's data strategy, enhancing the technological advancements led by Chief Technology and Data Officer Harpreet Khurana. In this capacity, Dr…
PR Newswire
10/11/2025

Partner Robotics raises Series A funding to deploy robots on construction sites…

For now, Partner Robotics is focusing on two products: Floor Tile Paving Robot P900 and Intelligent Scribing Robot L3000. Both address specific challenges and fit into what the company describes as a "high-value and feasible" product roadmap, with the long-term aim of covering the entire construction lifecycle with embodied intelligence solutions. Partner's Floor Tile Paving Robot P900 are designed to stabilize quality through precision parameter controls and reduce hollow spots. The…
PR Newswire
10/11/2025

TP Honored with Frost & Sullivan's 2025 Global Competitive Strategy Leadership…

Frost & Sullivan's independent analysis highlights TP's ability to reimagine traditional sales and customer engagement models in a rapidly evolving digital landscape. As organizations worldwide adapt to changing customer expectations and increasing technological complexity, TP stands out for its commitment to driving performance through innovation, emotional intelligence, and a globally unified vision. Frost & Sullivan's independent analysis highlights TP's ability to reimagine…
PR Newswire
10/11/2025

Evosep Unveils Open Innovation Initiative to Expand Standardization in…

HUPOWorldCongress – Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most persistent challenges: sample preparation. Building on its legacy of standardizing proteomics LC separation, Evosep is now expanding upstream to deliver robust, and reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics. What to ExpectEvotip based...
Nasdaq GlobeNewswire
10/11/2025

Mercuryo and LOBSTR Launch USDC Cashback Offer Rewarding Activity on Stellar…

"Stablecoins are playing a pivotal role in the crypto narrative of 2025 with USDC at the forefront," said Petr Kozyakov, Co-Founder and CEO at Mercuryo. "We are confident that LOBSTR's growing userbase will take full advantage of this USDC cashback offer as they leverage the wallet's interface to make active use of the Stellar network's blossoming ecosystem." "Stablecoins are playing a pivotal role in the crypto narrative of 2025 with USDC at the forefront," said…
PR Newswire
10/11/2025

PROPHETX SEEKS CFTC APPROVAL TO LAUNCH THE FIRST REGULATED SPORTS-NATIVE…

The filings represent a significant milestone in ProphetX's mission to bridge the gap between sports and traditional financial derivatives. By seeking dual registration as a DCM and DCO, ProphetX intends to operate a vertically integrated marketplace that allows users to directly trade, clear, and settle event-based contracts under full CFTC oversight. The filings represent a significant milestone in ProphetX's mission to bridge the gap between sports and traditional financial derivatives...
PR Newswire
10/11/2025

NYSE Content Advisory: Pre-Market Update + ICE Data Shows October Home Prices Up…

Opening BellEni (NYSE: E) celebrates 30th anniversary of listing Opening Bell Eni (NYSE: E) celebrates 30 thanniversary of listing Closing Bell Blackstone (NYSE: BX) celebrates its 40 thanniversary of founding Click here to download the NYSE TV App Video -https://mma.prnewswire.com/media/2818565/NYSE_Market_Update_November_10.mp4 Logo -https://mma.prnewswire.com/media/2581322/5612553/New_York_Stock_Exchange_Logo.jpg View original content: https://www...
PR Newswire
10/11/2025

Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver…

This post hoc analysis of the ESSENCE trial evaluated the first 800 randomized patients at 72 weeks. Histological and non-invasive testing (NIT)­–related treatment responses were evaluated according to specific weight loss thresholds (≤2%, ≤5%, ≤7%, >7%).1 Steatohepatitis-related NITs improved in all groups receiving semaglutide 2.4 mg, with the greatest treatment effect observed for alanine aminotransaminase (ALT) in patients with weight loss of ≤7%. In this subgroup, patients receiving…
PR Newswire
10/11/2025

Form 8.3 - Avadel Pharmaceuticals plc

FORM8.3IRISHTAKEOVERPANELDISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE1. KEYINFORMATIONNameofpersondealing(Note1) State Street Global Advisors & Affiliates Companydealtin Avadel Pharmaceuticals plc Classofrelevantsecuritytowhich the dealingsbeingdisclosedrelate(Note...
Nasdaq GlobeNewswire
10/11/2025

Transactions in connection with share buyback programme

On 5 February 2025, Pandora announced a new share buyback programme, cf. Company announcement no. 923. The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation). The purpose of the programme is to reduce...
Nasdaq GlobeNewswire
10/11/2025

Form 8.3 - Unite Group Plc

8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser: Rathbones Group Plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries...
Nasdaq GlobeNewswire
10/11/2025

Form 8.3 - Idox Plc

8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser: Rathbones Group Plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries...
Nasdaq GlobeNewswire
10/11/2025

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record…

Azurity is a high-growth global pharmaceutical company dedicated to creating new opportunities and markets for a broad range of established medications, while also developing innovative treatments for overlooked patient populations. Azurity’s goal is to identify gaps in care and provide patients with medicines that improve efficacy, access, safety, or the patient experience.With a portfolio of over 50 medicines across 10 dosage forms and 10 key therapeutic areas, Azurity leverages data and...
Nasdaq GlobeNewswire
10/11/2025

Abu Dhabi Investment Office announces 29 strategic partnerships to accelerate…

The 29 commercial agreements span critical sectors, from e-commerce, food and goods delivery with partners such as Integrated Transport Centre (AD Mobility), Talabat, Noon, and Aramex, to healthcare delivery and logistics with PureLab, and industrial logistics automation. The 29 commercial agreements span critical sectors, from e-commerce, food and goods delivery with partners such as Integrated Transport Centre (AD Mobility), Talabat, Noon, and Aramex, to healthcare delivery and logistics…
PR Newswire
10/11/2025
Altri  Comunicati